Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy
Cells · 29.11.2024 · 13 (23) · 1976
DOI: 10.3390/cells13231976 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 29.11.2024. Verfasst von Wenhua Qiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory for T Cell and Immunotherapy, State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Immunology, Ins…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Induced Pluripotent Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Initiative for Innovative Medicine, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system capable of killing virus-infected cells and/or cancer cells. The commonly used NK cells for therapeutic applications include primary NK cells and immortalized NK cell lines. However, primary NK cell therapy faces limitations due to its restricted proliferation capacity and challenges in stable storage. Meanwhile, the immortalized NK-92 cell line requires irradiation prior to infusion, which reduces its cytotoxic activity, providing a ready-made alternative and overcoming these bottlenecks. Recent improvements in differentiation protocols for iPSC-derived NK cells have facilitated the clinical production of iPSC-NK cells. Moreover, iPSC-NK cells can be genetically modified to enhance tumor targeting and improve the expansion and persistence of iPSC-NK cells, thereby achieving more robust antitumor efficacy. This paper focuses on the differentiation-protocols efforts of iPSC-derived NK cells and the latest progress in iPSC-NK cell therapy. Additionally, we discuss the current challenges faced by iPSC-NK cells and provide an outlook on future applications and developments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CAMS Key Laboratory for T Cell and Immunotherapy, State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences…
- Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy, Changzhou 213000, China.
Förderung
- CAMS Initiative for Innovative Medicine
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Beijing Municipal Commission of Science and Technology Fund for Innovative Drugs
- Changzhou Science and Technology Program
Zitieren
APA
Qiao, W., Dong, P., Chen, H., & Zhang, J. (2024). Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy. Cells, 13(23), 1976. https://doi.org/10.3390/cells13231976
Vancouver
Qiao W, Dong P, Chen H, Zhang J. Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy. Cells. 2024;13(23):1976. doi:10.3390/cells13231976
BibTeX
@article{Qiao2024,
author = {Qiao, Wenhua and Dong, Peng and Chen, Hui and Zhang, Jianmin},
title = {Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy},
journal = {Cells},
year = {2024},
volume = {13},
number = {23},
pages = {1976},
doi = {10.3390/cells13231976}
}
EUVIMED